Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Diabetes Software Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 For Smartphones
  • 1.4.3 For Tablet PC
  • 1.4.4 Web-based
• 1.5 Market by Application
  • 1.5.1 Global Diabetes Software Market Share by Application (2019-2025)
  • 1.5.2 Type 1 Diabetes
  • 1.5.3 Type 2 Diabetes
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Diabetes Software Market Size
• 2.2 Diabetes Software Growth Trends by Regions
  • 2.2.1 Diabetes Software Market Size by Regions (2019-2025)
  • 2.2.2 Diabetes Software Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Diabetes Software Market Size by by Players
  • 3.1.1 Global Diabetes Software Revenue by by Players (2014-2019)
  • 3.1.2 Global Diabetes Software Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Diabetes Software Market Concentration Ratio (CR5 and HHI)
• 3.2 Diabetes Software Key Players Head office and Area Served
• 3.3 Key Players Diabetes Software Product/Solution/Service
• 3.4 Date of Enter into Diabetes Software Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Diabetes Software Market Size by Type (2014-2019)
• 4.2 Global Diabetes Software Market Size by Application (2014-2019)

5 North America

• 5.1 North America Diabetes Software Market Size (2014-2019)
• 5.2 Diabetes Software Key Players in North America
• 5.3 North America Diabetes Software Market Size by Type
• 5.4 North America Diabetes Software Market Size by Application

6 Europe

• 6.1 Europe Diabetes Software Market Size (2014-2019)
• 6.2 Diabetes Software Key Players in Europe
• 6.3 Europe Diabetes Software Market Size by Type
• 6.4 Europe Diabetes Software Market Size by Application

7 China

• 7.1 China Diabetes Software Market Size (2014-2019)
• 7.2 Diabetes Software Key Players in China
• 7.3 China Diabetes Software Market Size by Type
• 7.4 China Diabetes Software Market Size by Application

8 Japan

• 8.1 Japan Diabetes Software Market Size (2014-2019)
• 8.2 Diabetes Software Key Players in Japan
• 8.3 Japan Diabetes Software Market Size by Type
• 8.4 Japan Diabetes Software Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Diabetes Software Market Size (2014-2019)
• 9.2 Diabetes Software Key Players in Southeast Asia
• 9.3 Southeast Asia Diabetes Software Market Size by Type
• 9.4 Southeast Asia Diabetes Software Market Size by Application

10 India

• 10.1 India Diabetes Software Market Size (2014-2019)
• 10.2 Diabetes Software Key Players in India
• 10.3 India Diabetes Software Market Size by Type
• 10.4 India Diabetes Software Market Size by Application

11 Central & South America

• 11.1 Central & South America Diabetes Software Market Size (2014-2019)
• 11.2 Diabetes Software Key Players in Central & South America
• 11.3 Central & South America Diabetes Software Market Size by Type
• 11.4 Central & South America Diabetes Software Market Size by Application

12 International Players Profiles

• 12.1 Glooko
  • 12.1.1 Glooko Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Diabetes Software Introduction
  • 12.1.4 Glooko Revenue in Diabetes Software Business (2014-2019))
  • 12.1.5 Glooko Recent Development
• 12.2 Accu-Chek (Roche)
  • 12.2.1 Accu-Chek (Roche) Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Diabetes Software Introduction
  • 12.2.4 Accu-Chek (Roche) Revenue in Diabetes Software Business (2014-2019)
  • 12.2.5 Accu-Chek (Roche) Recent Development
• 12.3 Tidepool
  • 12.3.1 Tidepool Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Diabetes Software Introduction
  • 12.3.4 Tidepool Revenue in Diabetes Software Business (2014-2019)
  • 12.3.5 Tidepool Recent Development
• 12.4 LifeScan, Inc (Platinum Equity)
  • 12.4.1 LifeScan, Inc (Platinum Equity) Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Diabetes Software Introduction
  • 12.4.4 LifeScan, Inc (Platinum Equity) Revenue in Diabetes Software Business (2014-2019)
  • 12.4.5 LifeScan, Inc (Platinum Equity) Recent Development
• 12.5 Pharmaco Diabetes
  • 12.5.1 Pharmaco Diabetes Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Diabetes Software Introduction
  • 12.5.4 Pharmaco Diabetes Revenue in Diabetes Software Business (2014-2019)
  • 12.5.5 Pharmaco Diabetes Recent Development
• 12.6 Ascensia Diabetes Care Holdings AG
  • 12.6.1 Ascensia Diabetes Care Holdings AG Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Diabetes Software Introduction
  • 12.6.4 Ascensia Diabetes Care Holdings AG Revenue in Diabetes Software Business (2014-2019)
  • 12.6.5 Ascensia Diabetes Care Holdings AG Recent Development
• 12.7 Diabeto Medtech India Pvt. Ltd
  • 12.7.1 Diabeto Medtech India Pvt. Ltd Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Diabetes Software Introduction
  • 12.7.4 Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Software Business (2014-2019)
  • 12.7.5 Diabeto Medtech India Pvt. Ltd Recent Development
• 12.8 Abbott Diabetes Care
  • 12.8.1 Abbott Diabetes Care Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Diabetes Software Introduction
  • 12.8.4 Abbott Diabetes Care Revenue in Diabetes Software Business (2014-2019)
  • 12.8.5 Abbott Diabetes Care Recent Development
• 12.9 Acon Diabetes Care International
  • 12.9.1 Acon Diabetes Care International Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Diabetes Software Introduction
  • 12.9.4 Acon Diabetes Care International Revenue in Diabetes Software Business (2014-2019)
  • 12.9.5 Acon Diabetes Care International Recent Development
• 12.10 BIONIME
  • 12.10.1 BIONIME Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Diabetes Software Introduction
  • 12.10.4 BIONIME Revenue in Diabetes Software Business (2014-2019)
  • 12.10.5 BIONIME Recent Development
• 12.11 Custo med
• 12.12 Dexcom
• 12.13 Dottli
• 12.14 GlucoMe
• 12.15 MyLife
• 12.16 Nova
• 12.17 Tandem Diabetes Care
• 12.18 Trividia Health

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.

In 2018, the global Diabetes Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetes Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetes Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health

Market segment by Type, the product can be split into
For Smartphones
For Tablet PC
Web-based

Market segment by Application, split into
Type 1 Diabetes
Type 2 Diabetes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetes Software status, future forecast, growth opportunity, key market and key players.
To present the Diabetes Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetes Software are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.